These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15642143)

  • 21. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoclast precursors, RANKL/RANK, and immunology.
    Xing L; Schwarz EM; Boyce BF
    Immunol Rev; 2005 Dec; 208():19-29. PubMed ID: 16313338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
    Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
    Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
    Makrygiannakis D; af Klint E; Catrina SB; Botusan IR; Klareskog E; Klareskog L; Ulfgren AK; Catrina AI
    Arthritis Rheum; 2006 May; 54(5):1463-72. PubMed ID: 16646024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone destruction in arthritis.
    Gravallese EM
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoclasts are essential for TNF-alpha-mediated joint destruction.
    Redlich K; Hayer S; Ricci R; David JP; Tohidast-Akrad M; Kollias G; Steiner G; Smolen JS; Wagner EF; Schett G
    J Clin Invest; 2002 Nov; 110(10):1419-27. PubMed ID: 12438440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.